Ann: Novartis and Mesoblast Remestemcel-L Collaboration, page-220

Really don’t like the way that MSB slipped in the comments about the fda emergency meeting not likely to be positive.

Actually were under no obligation to say anything as they had not received official response, lots announcements on one day and this slipped in.
I guess if this was released by itself MSB would have been in the mid $2 range, I think we should all keep this in mind after the excitement fades and the reality that without approvals nothing else matters.

MSB. NEEDS TO COVER ALL BASES AND GET AN APPROVAL OF SOMETHING NO EXCUSES THIS IS THEIR THING, THEY NEED TO OVERCOME, ANTICIPATE, MAKE SURE GET IT DONE.
DON’T TREAT YOUR STOCK HOLDERS LIKE FOOLS WITH TODAYS SLIGHT OF HAND.

Yes I know there’s a lot in play at the moment and of heard all the FDA are meanies and pharmaceuticals companies are evil if Trump wins if Biden wins, studies take time ,COVID delays blah blah blah.

Don’t question my knowledge or understanding or suggest I am down ramping . I have plus 100,000 shares so serious skin in the game and have been patient and understanding just don’t like game’s and in my opinion today’s release of announcements and slipping in the negative is insulting to the many loyal patient knowledgeable holders.